» Articles » PMID: 20531971

Overlap of Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis - a Rare Coincidence or a New Syndrome

Overview
Journal Int J Gen Med
Publisher Dove Medical Press
Specialty General Medicine
Date 2010 Jun 10
PMID 20531971
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Overlap syndrome has been introduced to the field of hepatology to describe the coexistence of two or more autoimmune hepatic conditions in the same individual. This is a rare clinical case of a patient diagnosed with primary biliary cirrhosis (PBC) who later developed primary sclerosing cholangitis (PSC). This is a unique case as no other cases with a similar pattern have been reported. Overlap syndrome does not include the coexistence of PBC and PSC as a distinctive syndrome so far.

Case Report: A middle-aged woman suffering from PBC for 17 years got admitted with clinical and biochemical features of cholestatic syndrome. A provisional diagnosis of worsening PBC was proved wrong by magnetic resonance cholangiopancreatography, which revealed typical benign stricture and dilatation of common bile duct with typical beading appearance suggestive of PSC. The patient was stented and treated with an increased dose of ursodeoxycholic acid (UDCA) which improved the symptoms and the biochemical picture.

Conclusion: This is a clear overlap of PBC-PSC. It is very difficult to say whether it is a rare coincidence or a new overlap syndrome, but there are no clear guidelines for management of these patients. Currently, the treatment involves endoscopic duct dilatation, UDCA, and regular follow-ups to rule out hepato-biliary tumor occurrence.

Citing Articles

Overlap syndrome of seronegative primary biliary cholangitis and small duct primary sclerosing cholangitis: a first case report and literature review.

Souissi S, Laabidi S, Mustpha N, Chelly I, Serghini M, Fekih M Future Sci OA. 2024; 10(1):FSO971.

PMID: 38817389 PMC: 11137790. DOI: 10.2144/fsoa-2023-0187.


Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review.

Mago S, Wu G J Clin Transl Hepatol. 2020; 8(3):336-346.

PMID: 33083257 PMC: 7562796. DOI: 10.14218/JCTH.2020.00036.


A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome.

Beretta-Piccoli B, Mazzucchelli L, Taiana C, Mossi G, Usai C, Vergani D J Transl Autoimmun. 2020; 3:100033.

PMID: 32743518 PMC: 7388380. DOI: 10.1016/j.jtauto.2019.100033.


Treatment of Overlap Syndromes in Autoimmune Liver Disease: A Systematic Review and Meta-Analysis.

Freedman B, Danford C, Patwardhan V, Bonder A J Clin Med. 2020; 9(5).

PMID: 32414025 PMC: 7291241. DOI: 10.3390/jcm9051449.


Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

Sundaram S, S K, Mazumdar S, Shukla A ACG Case Rep J. 2018; 5:e54.

PMID: 30038926 PMC: 6053546. DOI: 10.14309/crj.2018.54.


References
1.
Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A . Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996; 38(4):610-5. PMC: 1383124. DOI: 10.1136/gut.38.4.610. View

2.
Kaya M, Angulo P, Lindor K . Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J Hepatol. 2000; 33(4):537-42. DOI: 10.1034/j.1600-0641.2000.033004537.x. View

3.
Poupon R . Autoimmune overlapping syndromes. Clin Liver Dis. 2003; 7(4):865-78. DOI: 10.1016/s1089-3261(03)00092-8. View

4.
Kinoshita H, Omagari K, Whittingham S, Kato Y, Ishibashi H, Sugi K . Autoimmune cholangitis and primary biliary cirrhosis--an autoimmune enigma. Liver. 1999; 19(2):122-8. DOI: 10.1111/j.1478-3231.1999.tb00021.x. View

5.
Ataseven H, Parlak E, Yuksel I, Basar O, Ertugrul I, Sasmaz N . Primary sclerosing cholangitis in Turkish patients: characteristic features and prognosis. Hepatobiliary Pancreat Dis Int. 2009; 8(3):312-5. View